CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Therapy in men with low-risk to intermediate to high-risk localized prostate cancer who are candidates for, or have opted for, pros...
Miami, Florida, United States and 38 other locations
and with darolutamide in men with metastatic castration-resistant prostate cancer. The study aims to assess whether the drug is saf ...
Phase 1
Miami, Florida, United States and 12 other locations
(PK), pharmacodynamics, and preliminary efficacy of multiple anti-cancer agents in participants with metastatic prostate cancer...
Phase 1, Phase 2
Miami, Florida, United States and 32 other locations
The aim for this study is to investigate the ability of 64Cu-SAR-bisPSMA PET/CT to detect recurrence of prostate cancer...
Phase 3
Miami, Florida, United States of America and 23 other locations
Cu 64 PSMA I\&T injection for PET/CT imaging in patients with newly diagnosed unfavorable intermediate high-risk, high-risk or very high-risk prostate...
Phase 3
Miami, Florida, United States and 43 other locations
radiation therapy for patients with intermediate-high risk localized prostate cancer. ProstAtak kills tumor cells and stim...
Phase 3
Fort Lauderdale, Florida, United States and 72 other locations
The purpose of this study is to evaluate the safety, efficacy, tolerability, and pharmacokinetics (PK) of FG-3246, a cluster of differentiation 46 (C...
Phase 2
Hialeah, Florida, United States and 19 other locations
The main purpose of the study is to assess the safety and tolerability of AZD2284, AZD2287, and AZD2275.
Phase 1
Miami, Florida, United States and 15 other locations
multicenter, prospective, randomized clinical trial that aims to evaluate the safety and efficacy of Aquablation therapy in men with localized prostate...
Miami, Florida, United States and 16 other locations
plus prednisone in participants with metastatic castration resistant prostate cancer. Prednisolone may be used instead of prednison...
Phase 2, Phase 3
Hollywood, Florida, United States and 113 other locations
Clinical trials
Research sites
Resources
Legal